Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00037102
Status:
COMPLETED
Last Update Posted:
2018-04-12
First Post:
2002-05-15
Brief Title:
Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
Sponsor:
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Organization:
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Organization Data
Organization:
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Class:
OTHER
Study ID:
MANI-MTX01-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Vernon D Rowe III MD
Responsible Party Title:
Vernon D Rowe III MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Biogen | INDUSTRY |
| Consultants in Neurology | INDUSTRY |